Persistent tardive dyskinesia in bipolar patients.

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Tardive dyskinesia (TD) is a potential side effect of neuroleptic medications.
• Bipolar disorder treatment often involves neuroleptics and mood stabilizers like lithium.
• Understanding TD prevalence and risk factors in bipolar patients is crucial for treatment safety.

Purpose of the Study:

• To determine the prevalence and outcome of persistent tardive dyskinesia (TD) in bipolar patients.
• To identify predictors for the development of persistent TD in this population.

Main Methods:

• A cohort of 131 bipolar patients was studied.
• Patients were divided into subgroups based on neuroleptic treatment history.
• Multiple regression analysis was used to identify predictive variables for persistent TD.

Main Results:

• Persistent TD was diagnosed in 35.4% of bipolar patients with a history of neuroleptic treatment (34/96).
• No cases of persistent TD were observed in patients without prior neuroleptic exposure (0/35).
• Longer cumulative neuroleptic treatment duration and shorter previous lithium treatment duration predicted persistent TD, accounting for 36% of the variance.

Conclusions:

• Neuroleptic-treated bipolar patients face a significant risk of developing persistent TD.
• Persistent TD often continues despite lithium treatment and discontinuation of neuroleptics.
• Further research is needed to identify specific high-risk subgroups within neuroleptic-treated bipolar patients.